Characteristics of and Trends in the Late-stage Biopharmaceutical Pipeline
Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.
Review of Recent US Cost Estimates of Revascularization